サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1413102

ナチュラルキラー細胞治療薬市場：治療薬、アプローチ、用途、エンドユーザー別-2024-2030年の世界予測

Natural Killer Cell Therapeutics Market by Therapeutics (NK Cell Directed Antibodies, NK Cell Therapies), Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies), Application, End User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ナチュラルキラー細胞治療薬市場：治療薬、アプローチ、用途、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ナチュラルキラー細胞治療薬市場規模は2023年に53億1,000万米ドルと推計され、2024年には60億2,000万米ドルに達すると予測され、CAGR 11.94%で2030年には117億1,000万米ドルに達する見込みです。

ナチュラルキラー細胞治療薬の世界市場

主な市場の統計
基準年[2023］ 53億1,000万米ドル
予測年[2024］ 60億2,000万米ドル
予測年 [2030] 117億1,000万米ドル
CAGR（%） 11.94%
ナチュラルキラー細胞治療薬 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはナチュラルキラー細胞治療薬市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、ナチュラルキラー細胞治療薬市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-ナチュラルキラー細胞治療薬市場の市場規模および予測は？

2-ナチュラルキラー細胞治療薬市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-ナチュラルキラー細胞治療薬市場における技術動向と規制の枠組みは？

4-ナチュラルキラー細胞治療薬市場における主要ベンダーの市場シェアは？

5-ナチュラルキラー細胞治療薬市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中でガンの有病率が上昇
      • 副作用を最小限に抑えた標的療法への傾向
      • 免疫療法の大幅な改善
    • 抑制要因
      • ナチュラルキラー細胞治療薬に関連する高コスト
    • 機会
      • ナチュラルキラー細胞治療薬を改善するための継続的な研究開発
      • 新しいナチュラルキラー細胞治療薬の開発に有利な投資
    • 課題
      • ナチュラルキラー細胞治療薬に関連付けられた複雑さ
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 ナチュラルキラー細胞治療薬市場セラピューティクス別

  • NK細胞指向性抗体
  • NK細胞療法

第7章 ナチュラルキラー細胞治療薬市場アプローチ別

  • 抗体依存性細胞媒介性細胞毒性（ADCC）
  • 二重特異性抗体

第8章 ナチュラルキラー細胞治療薬市場：用途別

  • 急性感染症
  • がん
  • 消化器疾患
  • 免疫増殖性疾患

第9章 ナチュラルキラー細胞治療薬市場：エンドユーザー別

  • 病院
  • 調査および学術機関
  • 専門クリニック

第10章 南北アメリカのナチュラルキラー細胞治療薬市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域のナチュラルキラー細胞治療薬市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカのナチュラルキラー細胞治療薬市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Acepodia Inc.
    • Affimed N.V.
    • BioHaven Pharmaceutical Holding Company Ltd. by Pfizer Inc.
    • Celgene Corporation by Bristol-Myers Squibb Company
    • Celularity Inc.
    • Century Therapeutics, Inc.
    • Cytovac A/S
    • Dragonfly Therapeutics, Inc.
    • EMERcell
    • Fate Therapeutics, Inc.
    • Fortress Biotech, Inc.
    • Gamida Cell Ltd.
    • Glycostem Therapeutics B.V.
    • iCell Gene Therapeutics LLC
    • ImmunityBio, Inc. by NantWorks LLC
    • Innate Pharma S.A.
    • Kiadis Pharma N.V. by Sanofi S.A.
    • Merck KGaA
    • MiNK Therapeutics, Inc.
    • Multimmune GmbH
    • Nkarta, Inc.
    • PersonGen BioTherapeutics
    • Phio Pharmaceuticals Inc.
    • Regeneron Pharmaceuticals Inc.
    • Takeda Pharmaceutical Company Limited
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. NATURAL KILLER CELL THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. NATURAL KILLER CELL THERAPEUTICS MARKET DYNAMICS
  • FIGURE 7. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2023 VS 2030 (%)
  • FIGURE 8. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2023 VS 2030 (%)
  • FIGURE 10. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. NATURAL KILLER CELL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. NATURAL KILLER CELL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. NATURAL KILLER CELL THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 6. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY NK CELL DIRECTED ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY NK CELL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 9. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY (ADCC), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY BISPECIFIC ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY ACUTE INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY IMMUNOPROLIFERATIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 17. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPROACHES, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM NATURAL KILLER CELL THERAPEUTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. NATURAL KILLER CELL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 189. NATURAL KILLER CELL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. NATURAL KILLER CELL THERAPEUTICS MARKET LICENSE & PRICING
目次
Product Code: MRR-5C6F41F5B003

[184 Pages Report] The Natural Killer Cell Therapeutics Market size was estimated at USD 5.31 billion in 2023 and expected to reach USD 6.02 billion in 2024, at a CAGR 11.94% to reach USD 11.71 billion by 2030.

Global Natural Killer Cell Therapeutics Market

KEY MARKET STATISTICS
Base Year [2023] USD 5.31 billion
Estimated Year [2024] USD 6.02 billion
Forecast Year [2030] USD 11.71 billion
CAGR (%) 11.94%
Natural Killer Cell Therapeutics Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Natural Killer Cell Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Natural Killer Cell Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Natural Killer Cell Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Acepodia Inc., Affimed N.V., BioHaven Pharmaceutical Holding Company Ltd. by Pfizer Inc., Celgene Corporation by Bristol-Myers Squibb Company, Celularity Inc., Century Therapeutics, Inc., Cytovac A/S, Dragonfly Therapeutics, Inc., EMERcell, Fate Therapeutics, Inc., Fortress Biotech, Inc., Gamida Cell Ltd., Glycostem Therapeutics B.V., iCell Gene Therapeutics LLC, ImmunityBio, Inc. by NantWorks LLC, Innate Pharma S.A., Kiadis Pharma N.V. by Sanofi S.A., Merck KGaA, MiNK Therapeutics, Inc., Multimmune GmbH, Nkarta, Inc., PersonGen BioTherapeutics, Phio Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Natural Killer Cell Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Therapeutics
    • NK Cell Directed Antibodies
    • NK Cell Therapies
  • Approaches
    • Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
    • Bispecific Antibodies
  • Application
    • Acute Infectious Diseases
    • Cancer
    • Gastrointestinal Diseases
    • Immunoproliferative Disorders
  • End User
    • Hospitals
    • Research & Academic Institutes
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Natural Killer Cell Therapeutics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Natural Killer Cell Therapeutics Market?

3. What are the technology trends and regulatory frameworks in the Natural Killer Cell Therapeutics Market?

4. What is the market share of the leading vendors in the Natural Killer Cell Therapeutics Market?

5. Which modes and strategic moves are suitable for entering the Natural Killer Cell Therapeutics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Natural Killer Cell Therapeutics Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cancer worldwide
      • 5.1.1.2. Inclination towards targeted therapies with minimal side effects
      • 5.1.1.3. Significant improvements in immunotherapy
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with natural killer cell therapeutics
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing R&D to improve natural killer cell therapeutics
      • 5.1.3.2. Favorable investments for development of novel natural killer cell therapeutics
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity associated with natural killer cell therapeutics
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Natural Killer Cell Therapeutics Market, by Therapeutics

  • 6.1. Introduction
  • 6.2. NK Cell Directed Antibodies
  • 6.3. NK Cell Therapies

7. Natural Killer Cell Therapeutics Market, by Approaches

  • 7.1. Introduction
  • 7.2. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
  • 7.3. Bispecific Antibodies

8. Natural Killer Cell Therapeutics Market, by Application

  • 8.1. Introduction
  • 8.2. Acute Infectious Diseases
  • 8.3. Cancer
  • 8.4. Gastrointestinal Diseases
  • 8.5. Immunoproliferative Disorders

9. Natural Killer Cell Therapeutics Market, by End User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Research & Academic Institutes
  • 9.4. Specialty Clinics

10. Americas Natural Killer Cell Therapeutics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Natural Killer Cell Therapeutics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Natural Killer Cell Therapeutics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Acepodia Inc.
    • 14.1.2. Affimed N.V.
    • 14.1.3. BioHaven Pharmaceutical Holding Company Ltd. by Pfizer Inc.
    • 14.1.4. Celgene Corporation by Bristol-Myers Squibb Company
    • 14.1.5. Celularity Inc.
    • 14.1.6. Century Therapeutics, Inc.
    • 14.1.7. Cytovac A/S
    • 14.1.8. Dragonfly Therapeutics, Inc.
    • 14.1.9. EMERcell
    • 14.1.10. Fate Therapeutics, Inc.
    • 14.1.11. Fortress Biotech, Inc.
    • 14.1.12. Gamida Cell Ltd.
    • 14.1.13. Glycostem Therapeutics B.V.
    • 14.1.14. iCell Gene Therapeutics LLC
    • 14.1.15. ImmunityBio, Inc. by NantWorks LLC
    • 14.1.16. Innate Pharma S.A.
    • 14.1.17. Kiadis Pharma N.V. by Sanofi S.A.
    • 14.1.18. Merck KGaA
    • 14.1.19. MiNK Therapeutics, Inc.
    • 14.1.20. Multimmune GmbH
    • 14.1.21. Nkarta, Inc.
    • 14.1.22. PersonGen BioTherapeutics
    • 14.1.23. Phio Pharmaceuticals Inc.
    • 14.1.24. Regeneron Pharmaceuticals Inc.
    • 14.1.25. Takeda Pharmaceutical Company Limited
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing